Radcliffe Capital Management, L.P. - LAVA MEDTECH ACQUISITION COR ownership

LAVA MEDTECH ACQUISITION COR's ticker is and the CUSIP is 519345110. A total of 34 filers reported holding LAVA MEDTECH ACQUISITION COR in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of LAVA MEDTECH ACQUISITION COR
ValueSharesWeighting
Q1 2023$5,838
-99.2%
69,6640.0%0.00%
-100.0%
Q4 2022$714,056
+2.0%
69,6640.0%0.02%
+35.3%
Q3 2022$700,000
+35.4%
69,664
+34.3%
0.02%
+41.7%
Q2 2022$517,0000.0%51,8600.0%0.01%0.0%
Q1 2022$517,000
+3.4%
51,860
+3.7%
0.01%
-7.7%
Q4 2021$500,00050,0000.01%
Other shareholders
LAVA MEDTECH ACQUISITION COR shareholders Q2 2022
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 69,664$714,0560.02%
LMR Partners LLP 12,500$127,3750.00%
GRITSTONE ASSET MANAGEMENT LLC 115,179$5870.00%
Schonfeld Strategic Advisors LLC 74,982$3820.00%
Fort Baker Capital Management LP 245,000$1,2490.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Sculptor Capital LP 186,500$1,6320.00%
BALYASNY ASSET MANAGEMENT L.P. 187,500$9560.00%
WHITEBOX ADVISORS LLC 25,000$1280.00%
MILLENNIUM MANAGEMENT LLC 77,500$00.00%
View complete list of LAVA MEDTECH ACQUISITION COR shareholders